MondoGen
Munich
About MondoGen
MondoGen is a biotechnology company that focuses exclusively on the development of liver-specific gene therapy systems. Based on a version of the hepatitis B virus that is unable to cause disease, MondoGen's technology enables highly efficient transfer of genes into liver cells. MondoGen is applying its technology to develop therapeutics against viral, malignant and inherited liver disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
Canonical: https://fsome.com/organization/mondogen-1467404 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.